10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

GILEAD SCIENCES, INC.

Ticker: GILD   Fiscal Year: 2021

Consolidated Statements of Income

Period Ending Dec 31, 2021 10-K (Filed: Feb 23, 2022)

(In Millions)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2021Dec 31, 2020Dec 31, 2019
Revenues:
Total revenues
$
27,305
24,68922,449
Costs and expenses:
Cost of goods sold6,6014,5724,675
Research and development expenses5,3635,0394,055
Acquired in-process research and development expenses1775,8565,051
Selling, general and administrative expenses5,2465,1514,381
Total costs and expenses17,38720,61818,162
 
Income from operations9,9184,0714,287
 
Interest expense(1,001)(984)(995)
Other income (expense), net(639)(1,418)1,868
Income before income taxes8,2781,6695,160
 
Income tax (expense) benefit(2,077)(1,580)204
Net income6,201895,364
 
Net loss attributable to noncontrolling interest243422
Net income attributable to Gilead6,2251235,386
 
Net income per share attributable to Gilead common stockholders - basic (in dollars per share)4.960.104.24
Shares used in per share calculation - basic (in shares)1,2561,2571,270
Net income per share attributable to Gilead common stockholders - diluted (in dollars per share)4.930.104.22
Shares used in per share calculation - diluted (in shares)1,2621,2631,277
Product and Service
Product sales
Total revenues27,00824,35522,119
Royalty, contract and other revenues
Total revenues297334330
External Links 
GILEAD SCIENCES, INC. (GILD) Fiscal Year 2021
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip